Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study

被引：0
作者：
S. Rahal
J M Boher
J M Extra
C. Tarpin
E. Charafe-Jauffret
E. Lambaudie
R. Sabatier
J. Thomassin-Piana
A. Tallet
M. Resbeut
G. Houvenaeghel
L. Laborde
F. Bertucci
P. Viens
A. Gonçalves
机构：
[1] Institut Paoli-Calmettes,Department of Medical Oncology
[2] Institut Paoli-Calmettes,Department of Biostatistics
[3] Institut Paoli-Calmettes,Department of Biopathology
[4] Institut Paoli-Calmettes,Department of Surgical Oncology
[5] Institut Paoli-Calmettes,Department of Radiation Oncology
[6] Institut Paoli-Calmettes,Data Management and Analysis Center
[7] U1068 INSERM,Centre de Recherche en Cancérologie de Marseille
[8] U7258 CNRS,undefined
[9] Aix-Marseille University,undefined
来源：
BMC Cancer | / 15卷
关键词：
Breast cancer; Adjuvant chemotherapy; Anthracycline; Taxane; Peritumoral vascular invasion; Molecular subtypes; Prognostic factors; Node-negative;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 211 条
[41]  
Adrover E(2008)Development of the 21-gene assay and its application in clinical practice and clinical trials J Clin Oncol Off J Am Soc Clin Oncol 26 721-undefined
[42]  
Martín M(undefined)undefined undefined undefined undefined-undefined
[43]  
Ruiz A(undefined)undefined undefined undefined undefined-undefined
[44]  
Ruiz Borrego M(undefined)undefined undefined undefined undefined-undefined
[45]  
Barnadas A(undefined)undefined undefined undefined undefined-undefined
[46]  
González S(undefined)undefined undefined undefined undefined-undefined
[47]  
Calvo L(undefined)undefined undefined undefined undefined-undefined
[48]  
Von Minckwitz G(undefined)undefined undefined undefined undefined-undefined
[49]  
Untch M(undefined)undefined undefined undefined undefined-undefined
[50]  
Blohmer J-U(undefined)undefined undefined undefined undefined-undefined
12345678910